Elsevier at a glance

Empowering knowledge

We want to make analysis easier for everyone working in science and medicine. Growing from our roots in publishing, we help you manage work efficiently so you can spend more time making breakthroughs.

Download the expanded PDF for more

Opportunities abound desktop

Opportunities abound

Technological advancement and the data revolution have pushed the boundaries of science and medicine.

Discoveries unimaginable a generation ago are uncovered every day. At Elsevier, we recognize the potential for scientists and clinicians to find new answers, reshape human knowledge and tackle the most urgent global crises.

We want to make analysis easier for everyone working in science and medicine, enabling them to manage their work more efficiently and spend more time making breakthroughs. That's why Elsevier is evolving. Growing from our roots in publishing, we're creating analytical solutions to serve the needs of science and health.

Elsevier employs over 1,000+ technologists.

Elsevier employs over 1,000+ technologists

81%
of our revenue comes from digital products.

Technology stock image

Assessment items

530+ m
standardized assessment items administered by HESI to students in North America in the past 12 years.

Scientific facts

475 m
scientific facts extracted from ScienceDirect using machine reading.

Data

4 TB
data of about 9,000 institutions in over 180 countries, turned into 171 trillion metrics per week using big data analytics since 1996.

.

Trusted information

Every tool we develop is built on trusted information.

From the library to the lab, from the institution to the individual, scientific and medical advancement requires reliable data. At Elsevier, we have partnered with the scholarly community for 140 years to curate and verify knowledge. Now, as an information analytics business, we're committed to bringing that rigor to a new generation of Elsevier platforms – especially at a time when it's harder than ever to know what to believe.

Trusted information2 desktop

ScienceDirect user distribution continues to expand

In 2018, Elsevier's article output accounted for 17% of global research output while garnering a 25% share of citations, demonstrating Elsevier's commitment to delivering research quality significantly ahead of the industry average.

People icon

14+ m
people a month use ScienceDirect, our flagship platform for academic research.

Assessment items

900+ m
full text articles downloaded in 2017.  That is 29 articles a second.

Analytics advantage desktop

Analytics advantage

We provide advanced technology and analytics to filter, extract and learn from vast data sets.

As well as enriching science, the proliferation of data brings new challenges for those striving for progress.  Vast volumes of information are hard to navigate and organize, increasing the risk of critical data being overlooked. It's tougher to ensure the credibililty of data. Research and healthcare are more complex when incorporating findings from multiple disciplines. In the globalized academic community, there is more competition than ever for jobs, students and funding.

E-books icon

38,000+
With more than 38,000 e-books from Elsevier, our imprints and our society partners, ScienceDirect empowers smarter research.

Active journals

22,500+
The largest abstract and citation database of peer-reviewed literature, Scopus contains more than 22,500 active journals.

Pharma innovators

320+
Reaxys®'s ML capability enable the chemistry of drug discovery, and materials innovation for over 320 pharma innovators, 130 chemical companies and over 1100 universities.

Mendeley users icon

~9 m
Mendeley enables around 9 million users worldwide, from undergraduates to professionals, to organize, write, collaborate and promote their research.

clinicalkey-professionals-icon

3+ m
Each month on ClinicalKey, thousands of clinical professionals, instructors and students log 1 million sessions, resulting in over 3 million views of content.

Sherpath users icon

33,000+
Sherpath provides highly focused, personalized and adaptive learning paths for over 33,000 users at over 400 institutions in 2017.

Research institutions icon

9,000+
SciVal offers insights into the research performance of over 9,000 research institutions.

International publishers icon

5,000
With over 70 million publications from 5,000 international publishers, Scopus allows researchers to track, analyze and visualize the world's research output.

A&G-institutions-icon

25,000+
Our Elsevier products are used at more than 25,000 Academic and Government institutions around the world.

Top health systems icon

98%
Clinical Solutions products are used in 7 of the top 10 pharmacy chains; 98% of the top 100 Health Systems (ranked by bed count) in the United States use at least one of Elsevier's Clinical Solutions.

Category leader icon

category leader
Elsevier Care Planning was named a 2018 Category Leader for the "Clinical Decision Support - Care Plans/Order Sets" catgegory, as determined by KLAS.

Clinical Pharmacology icon

best in KLAS
Clinical Pharmacology powered by ClincalKey™ is recognized as a top performer in the 2018 Best in KLAS® report for Clinical Decision Support - Point of Care Clinical Reference.

Our tools are designed to put users in control. They enable faster ways of working, manage complexity and free up time to focus on goals. And users can see how recommendations have been reached.

.

A shared partnership

Throughout Elsevier, we share the research community's belief in what science can achieve.

Shared partnership

Many of our people began their careers in science and medicine, and we work with a worldwide network of editors, authors and specialists, covering hundreds of disciplines.

Elsevier has 140 years of experience in curation and verification.

Editorial board members icon

87,000
editorial board members.

Trusted reviewers icon

1 m
trusted reviewers.

Editors in academia icon

22,000
editors in academia.

100+ developing countries

A founding partner and leading contributor.

We provide more than 80,000 peer-reviewed resources to researchers in over 100 developing countries. As a founding partner and the leading contributor, Elsevier provides over a quarter of the material available in Research4Life, encompassing around 3,000 Elsevier journals and 20,000 e-books and access to Scopus and Mendeley.

Collaborating closely with the community means we can respond quickly to genuine needs faced by those in the field. And it allows us to think ahead and address challenges science and medicine may face in the future.

Navigating change

Elsevier believes in making every part of the research lifecycle simpler, more connected and more transparent.

As technology and data bring further change, there will be an even greater need to look at how the system that supports science can be improved. We are determined to lead the way and work with the community to develop solutions that achieve this mission.

Elsevier is where you are to support you.

Ultimately, enhancing the system that underpins science and medicine will help researchers and clinicians solve the 21st century's most challenging problems.